InvestorsHub Logo
Followers 40
Posts 3318
Boards Moderated 0
Alias Born 08/18/2009

Re: None

Wednesday, 03/27/2019 7:49:59 PM

Wednesday, March 27, 2019 7:49:59 PM

Post# of 1141
Great presentation at Roth last week -- succinct and exuding confidence.
http://wsw.com/webcast/roth33/dyai/

Also some notes from the call earlier:

are fully reporting per SEC rules
nasdaq approval imminent (some outstanding comments)
Q1 initiated projects including AAV on C1
2018 : 9 paid POC collaborations
2019 so far: 2 funded POCs research collab with top 25 pharma
various stages of negotiations POCs / research progs and other collabs with large and small biotech co's
> 100 NDA's and "several dozen material transfer agreements" signed to date

pipeline bulging with opportunity
variety of negotiations
a lot of with Big Pharma, some with CDMOs
expect more deals to come.. 2 or more in Q2 alone


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent DYAI News